A joint drug is any medication used to treat pain, inflammation, or disease in the joints. These range from over-the-counter pills you can pick up at a pharmacy to powerful prescription therapies that suppress specific parts of the immune system. The right one depends on what’s causing your joint problem, how severe it is, and how long you’ve been dealing with it.
Over-the-Counter Pain Relievers
For most people with joint pain, the first line of treatment is a nonsteroidal anti-inflammatory drug, commonly called an NSAID. Ibuprofen, naproxen, and aspirin all fall into this category. They work by blocking an enzyme that produces compounds called prostaglandins, which drive inflammation and pain signaling. When that enzyme is suppressed, swelling goes down and pain eases. These drugs handle mild to moderate joint pain effectively, and you can buy them without a prescription.
The tradeoff with NSAIDs is that long-term use carries real risks. They account for roughly 30% of hospital admissions tied to adverse drug reactions. About 13 to 15% of regular NSAID users develop upper gastrointestinal problems like stomach ulcers, and a quarter of all peptic ulcer cases may be caused by NSAID use alone. Chronic use also raises the risk of cardiovascular disease and kidney damage.
Topical Gels and Creams
If you want the benefits of an NSAID without as much systemic exposure, topical versions are worth considering. Diclofenac gel, applied directly to the skin over a painful joint, delivers comparable pain relief to oral diclofenac in clinical trials. The difference shows up in side effects: gastrointestinal problems occurred in 39% of people taking the oral version versus 25.4% using the topical form. Liver enzyme elevations, a marker of liver stress, were also significantly lower with the topical route (10.4% vs. 22.2% for oral). Because less of the drug enters the bloodstream, the topical form is gentler on the stomach, liver, and kidneys while still reducing pain at the joint itself.
Corticosteroid Injections
Steroid injections deliver a powerful anti-inflammatory drug directly into a joint. They’re commonly used for knee osteoarthritis and other localized joint problems when pills or topical treatments aren’t enough. The relief, however, is typically modest and short-lived. Systematic reviews show the average benefit lasts only 2 to 4 weeks compared to a placebo injection. Because the effect wears off quickly, people often receive up to four injections per year. Steroid injections work best as a bridge, buying time while other treatments take hold, rather than as a standalone long-term strategy.
Disease-Modifying Drugs for Arthritis
When joint damage stems from an autoimmune condition like rheumatoid arthritis, pain relievers alone won’t stop the disease from progressing. That’s where disease-modifying antirheumatic drugs come in. These medications don’t just mask symptoms. They slow or halt the immune system’s attack on joint tissue.
Conventional versions, like methotrexate, are small molecules made in a lab that broadly suppress the immune system. They’ve been a cornerstone of rheumatoid arthritis treatment for decades. Biologic versions are a newer class, made from living cells, that target specific proteins involved in inflammation rather than dampening the whole immune system. Some biologics block a protein called tumor necrosis factor that drives joint destruction, while others target immune cells called B-cells. Because they’re more precise, biologics can be effective for people who don’t respond to conventional options.
Newer Targeted Therapies
JAK inhibitors represent a more recent addition to the toolkit for inflammatory joint diseases. These are oral medications that block a specific signaling pathway inside immune cells, interrupting the chain of events that leads to joint inflammation. Three have been approved for rheumatoid arthritis in the U.S., starting in 2012. They offer an alternative for patients who haven’t improved with older medications.
The enthusiasm around JAK inhibitors has been tempered by safety data. The FDA has flagged increased risks of serious cardiovascular events, blood clots, infections, and certain cancers. Each drug in the class carries a somewhat different risk profile. For someone with existing heart disease risk factors, one option may be safer than another. These are typically reserved for cases where other treatments have failed, and the decision involves careful weighing of benefits against these specific risks.
Hyaluronic Acid Injections
Hyaluronic acid is a substance that naturally exists in joint fluid, where it acts as a lubricant and shock absorber. In osteoarthritis, this fluid breaks down. Injecting synthetic hyaluronic acid directly into the knee, a process called viscosupplementation, aims to restore some of that cushioning. These injections are FDA-approved specifically for knee osteoarthritis in people who haven’t responded to simpler treatments like acetaminophen or physical therapy.
Among all injectable and oral options studied for knee osteoarthritis pain, hyaluronic acid injections produced the largest effect size (0.63), outperforming oral painkillers, which had the smallest effect (0.18 for acetaminophen). The improvements in pain and function are described as small but clinically meaningful compared to placebo injections.
Glucosamine and Chondroitin Supplements
Glucosamine and chondroitin are dietary supplements, not prescription drugs, but they’re among the most widely used products for joint health. Both are natural components of cartilage. The idea behind supplementing them is to support cartilage maintenance and slow its breakdown.
A large systematic review covering 146 studies found that over 90% of efficacy studies reported positive outcomes, and most safety studies indicated minimal or no adverse effects. The standard dosing used in research is 1,500 mg of glucosamine and 1,200 mg of chondroitin per day, typically split into two or three doses. Beyond pain relief, several studies found that the combination reduced markers of cartilage breakdown and slowed joint space narrowing, a sign of cartilage loss visible on X-rays. These supplements are generally well-tolerated, though they take weeks to months to show effects and don’t work for everyone.
How Joint Drugs Differ by Condition
The type of joint drug that makes sense depends heavily on what’s happening in the joint. Osteoarthritis, where cartilage gradually wears away, is typically managed with a stepwise approach: topical or oral NSAIDs first, then injections or supplements if those aren’t enough. The goal is pain management and preserving function, since there’s no drug that reverses cartilage loss once it’s gone.
Inflammatory conditions like rheumatoid arthritis require a fundamentally different strategy. Because the immune system is actively destroying joint tissue, treatment focuses on slowing that process with disease-modifying drugs or biologics. Pain relievers still play a role for symptom control, but they’re not the main event. Starting disease-modifying therapy early, ideally within months of diagnosis, gives the best chance of preventing permanent joint damage.